Cargando…

Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial

BACKGROUND: In clinical practice, concomitant treatment of orlistat with phentermine is commonly used off-label. However, clinical trials have not been performed to evaluate whether their combination improves metabolic parameters and cardiovascular risk factors other than weight loss. Therefore, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Yu-Jin, Lee, Hyangkyu, Nam, Chung Mo, Chang, Hyuk-Jae, Yoon, Young-Ran, Lee, Hye Sun, Lee, Ji-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936679/ https://www.ncbi.nlm.nih.gov/pubmed/33688228 http://dx.doi.org/10.2147/DMSO.S300342

Ejemplares similares

Pulmonary Hypertension Associated with Use of Phentermine
por: Bang, Woo-Dae, et al.
Publicado: (2010)

Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013)

RE: Pulmonary Hypertension Associated with Use of Phentermine?
por: Hendricks, Ed J., et al.
Publicado: (2011)

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics
por: Kim, Eunju, et al.
Publicado: (2023)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

Obesity pillars roundtable: Phentermine – Past, present, and future
por: Bays, Harold Edward, et al.
Publicado: (2022)

Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
por: Kim, Hyun Ok, et al.
Publicado: (2013)

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

Abstract: Phentermine: A Systematic Review for Plastic & Reconstructive Surgeons
por: Lim, Soobin, et al.
Publicado: (2018)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report
por: Homola, Jaclyn, et al.
Publicado: (2018)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Phentermine Use During First and Second Trimesters Associated with Fetal Stroke
por: D'Adesky, Nathan, et al.
Publicado: (2019)

Phentermine-Associated Atrial Fibrillation: A Case Report and Literature Review
por: Manasrah, Nouraldeen, et al.
Publicado: (2022)

Effect of Phentermine on Hepatic Steatosis in Bariatric Surgery: A Pilot Study
por: Pérez-Cruz, Elizabeth, et al.
Publicado: (2022)

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022)

Effects on Weight Reduction and Safety of Short-Term Phentermine Administration in Korean Obese People
por: Kim, Kyoung Kon, et al.
Publicado: (2006)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

Greater hunger and less restraint predict weight loss success with phentermine treatment
por: Thomas, Elizabeth A., et al.
Publicado: (2015)

Three- and six-month efficacy and safety of phentermine in a Mexican obese population
por: Márquez-Cruz, Maribel, et al.
Publicado: (2021)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

A case of phentermine-induced psychosis: the need for caution for drug-drug interactions
por: Sreevalsam Anil, S., et al.
Publicado: (2023)

Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model
por: Go, Ryeo-Eun, et al.
Publicado: (2014)

Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report
por: Jo, Hyun-Sic, et al.
Publicado: (2019)

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

Coadministration of lorcaserin and phentermine for weight management: A 12‐week, randomized, pilot safety study
por: Smith, Steven R., et al.
Publicado: (2017)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Investigating interactions between phentermine, dexfenfluramine, and 5-HT(2C) agonists, on food intake in the rat
por: Grottick, Andrew J., et al.
Publicado: (2014)

Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings after 12 week-treatment: Randomized Sub-study
por: Rebello, Candida, et al.
Publicado: (2018)

Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
por: Rocha-González, Héctor Isaac, et al.
Publicado: (2021)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

Lorcaserin vs. Phentermine among non-surgical and surgical obese patients: Anthropometric, glycemic, lipid, safety and cost outcomes
por: Elhag, Wahiba, et al.
Publicado: (2019)

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study(1)(2)(3)
por: Garvey, W Timothy, et al.
Publicado: (2012)

Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
por: Salazar-Valencia, Itzel G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmg4engk640eoj3toq1erertb3